Discover 1,024 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,024
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Evaluation of Speech and Voice Biomarkers in Association With Burnout
for
Burnout, Burnout, Healthcare Workers
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 18+
Code: NCT07780812
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Minneapolis MN, Lake Barrington IL,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05413421
Phase 1, Recruiting
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: Minneapolis MN, Rochester MN, Fort Wayne IN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07095452
Phase 2, Phase 3, Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
for
Low Grade Serous Ovarian Cancer
Location: Minneapolis MN, Evanston IL, St Louis MO, Detroit MI,
Sponsor: Verastem, Inc.
Sex: Female
Age: 18+
Code: NCT06072781
Phase 3, Recruiting
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: Minneapolis MN, Hinsdale IL, Saint Louis MO,
Sponsor: Kartos Therapeutics, Inc.
Sex: Female
Age: 18+
Code: NCT05797831
Phase 2, Phase 3, Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Minneapolis MN, Iowa City IA, Milwaukee WI, Omaha NE,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
for
Endometrial Cancer
Location: Minneapolis MN, Sioux Falls SD, Peoria IL, Urbana IL,
Sponsor: BioNTech SE
Sex: Female
Age: 18+
Code: NCT06340568
Phase 3, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Minneapolis MN, Rochester MN, Chicago IL, Ann Arbor MI,